ABCA1 and Alzheimer disease: The LXR/ABCA1 axis is a very promising therapeutic target for Alzheimer’s disease (AD), wherein dysfunction in CNS cholesterol metabolism and the abnormal accumulation of toxic amyloid β (Aβ) peptides have been reported.